Successful Treatment of Refractory Lymphocytic Esophagitis With Vedolizumab

Am J Gastroenterol. 2019 Sep;114(9):1555-1556. doi: 10.14309/ajg.0000000000000350.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Budesonide / therapeutic use
  • Deglutition Disorders / etiology
  • Endoscopy, Digestive System
  • Esophagitis / complications
  • Esophagitis / drug therapy*
  • Esophagitis / pathology
  • Gastrointestinal Agents / therapeutic use*
  • Glucocorticoids / therapeutic use
  • Heartburn / etiology
  • Humans
  • Lymphocytes / pathology
  • Male
  • Omeprazole / therapeutic use
  • Proton Pump Inhibitors / therapeutic use
  • Treatment Failure
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Gastrointestinal Agents
  • Glucocorticoids
  • Proton Pump Inhibitors
  • Budesonide
  • vedolizumab
  • Omeprazole